Sign in
4

Changes in Ownership

CHARLES RIVER LABORATORIES INTERNATIONAL, INC. Filed Acc 0001127602-21-023433

EVP, Corp Strategy & Develop sold 3,700 shares at an average $402.21 ($1,488,175)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-08-06 Sale −1,458 $400.91 $584,522 10,704 D: show line 1 in the form
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-08-06 Sale −900 $401.66 $361,498 9,804 D: show line 2 in the form
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-08-06 Sale −1,042 $402.43 $419,335 8,762 D: show line 3 in the form
LaPlume Joseph W EVP, Corp Strategy & Develop 2021-08-06 Sale −300 $409.40 $122,820 8,462 D: show line 4 in the form
Open-market sales · 3,700 sh · avg $402.21 · $1,488,175
Loading xslF345X03/form4.xml…